In an unexpected twist, Pfizer ( NYSE:PFE ), the U.S. pharmaceutical giant, has defied market expectations by reporting a surprise quarterly profit. This surprising turnaround can be attributed to the resilient demand for COVID-related products, outperforming the company's own projections. The earnings report for the fourth quarter revealed adjusted earnings of 10...
Dear traders,
Pfizer is already in a strong support level, around 28$. Additionally it comes from a downtrend which definetly needs a correction, lets take advantage y set our targets arount 34.8 - 42.8.
Best of trading
A viewer on my Livestream Friday brought to my attention that Pfizer NYSE:PFE is coming off a major low (COVID Low) and has done a pullback to the 50% of the Impulse Move off said low. This is why I love doing Livestreams and having a trading community... idea crowdsourcing!
I like these setups especially as the S&P 500 and many stocks within it are making new...
Conservative Trend Trade 1F
+ long impulse
+ JOC test level
+ 1/2 correction
+ biggest untested volume Sp
Calculated affordable stop loss
1 to 2 R/R take profit with possible extension to 1/2 for monthly range
Monthly context
+ long balance
- expanding ICE
+ 1/2 correction
+ biggest volume manipulation withou result
PFE chart - Mid term/Longer term
Pretty bullish overall, but there is some downside showing (24, 18)
These points make some excellent buy zones.
Watch that first rejection trend
Really strong rejection trend at the top (thick red)
I'm liking 54 as an exit, but there is potential to fly past that.
Idk, I think at some point we see the downside of 18-17, but I'm...
NYSE:PFE
fpize made all time high with impulse 12345 wave during COVID-19
now the price is around 0.618 fib area
with ABC correction wave
and also in 1D chart
descending triangle broken with volume
and creating potential rev H&S
if the pice make new high it will be 200% profit
how you guys think about pfizer??
In a significant stride towards enhancing public health, Health Canada has recently granted approval for Pfizer's groundbreaking bivalent Respiratory Syncytial Virus (RSV) vaccine, ABRYSVO™. This development is a crucial step in safeguarding both older adults and infants through maternal immunization. With the potential to revolutionize preventive healthcare,...
PFE have risen from crucial 0.786 fibo and currently WYCKOFF Accumulation is formed and stable.
SL is $27-$28 and year end target is shown.
Bullish structure.
Pfizer is experiencing the most aggressive sell-off in its history and technicals are aligning for a possible reversal. The stock has given back all of its COVID-19-induced gains and probably giving us a first entry opportunity.
Here in this video, I break down very specifically why I think that NYSE:PFE is going up. Please pay attention and retain the information! Thank you as always for watching my analysis and I pray you have a beautiful new years!
Colossians 3:23-24
Not a recommendation, educational purpose only. This is one of the stocks that has been falling constantly throughout the year and now appears to be bouncing back. I bought some in 28s and sold covered call at 29 recently, not so lucky as the stock is nearing $30. It is possible, this can retest $25 -$26, the stock has potential to hit T1= $31.5, T2 = $34...
I have been following PFE for a while last year and almost added it as a staple to my core dividend portfolio which is about 25% of my long-term investing portfolio. The stock just printed its first whole bodied green candle since December of two years ago. The RSI is at historical levels not seen since 2009. The PE ratio has expanded a bit but still offers some...
Buying some NYSE:PFE shares at current level of support, SL at roughly $26 aiming for a risk-reward of 1:3.
Reason to enter this trade - price is at key support level, with bullish ice cream bar formed at weekly levels (week of 18th Dec 2023).
First trade of 2024, let's start the year with a bang!
PFE Pfizer, a darling of the Covid pandemic era is currently down from 56$
Pfizer emerged as a significant beneficiary during the Covid-19 era, witnessing a surge in its stock price. However, as the Covid-19 concern recedes, its share price has also returned most of its gains. Nevertheless, Pfizer's success isn't solely dependent on a single event, as it...
PFE hit a high of $62 and has since dropped more then 50% of the value. Looking at the waves, if fibo 0.786 holds then it would likely be a V recovery.
Watch this space.
